ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Neuromusculoskeletal Medicine OMM

Top Neuromusculoskeletal Medicine OMM Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT BAKER MD

Neuromusculoskeletal Medicine OMM

13,450

$539K

488
436 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 43%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 8%

$40
Average prescription price

Avg: $74

THAO HOANG D.O.

Neuromusculoskeletal Medicine OMM

5,096

$233K

230
197 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 43%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 8%

$46
Average prescription price

Avg: $74

SAN WIN M.D

Neuromusculoskeletal Medicine OMM

3,721

$41.3K

212
199 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

22%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 8%

$11
Average prescription price

Avg: $74

KULVEEN SACHDEVA M.D.

Neuromusculoskeletal Medicine OMM

2,977

$949K

302
252 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

5%
patients receiving schedule three controlled substances

Avg: 43%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 8%

$319
Average prescription price

Avg: $74

LUIS NATALI MD

Neuromusculoskeletal Medicine OMM

2,605

$287K

432
179 are 65+

36%
patients receiving schedule two controlled substances

Avg: 8%

28%
patients receiving schedule three controlled substances

Avg: 43%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 8%

$110
Average prescription price

Avg: $74

MICHAEL BAKER M.D.

Neuromusculoskeletal Medicine OMM

1,856

$247K

113
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 43%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 8%

$133
Average prescription price

Avg: $74

DHIA ALWARDI MD

Neuromusculoskeletal Medicine OMM

1,069

$114K

141
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 8%

$107
Average prescription price

Avg: $74

DARIUS SOLEIMANY M.D.

Neuromusculoskeletal Medicine OMM

1,018

$147K

110
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

19%
patients receiving schedule three controlled substances

Avg: 43%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 8%

$144
Average prescription price

Avg: $74

MARKO PETROVIC M.D.

Neuromusculoskeletal Medicine OMM

968

$318K

201
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 8%

$329
Average prescription price

Avg: $74

PAUL KAPLAN M.D.

Neuromusculoskeletal Medicine OMM

948

$94.4K

44
0 are 65+

41%
patients receiving schedule two controlled substances

Avg: 8%

61%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 8%

$100
Average prescription price

Avg: $74

DAVID KULL MD

Neuromusculoskeletal Medicine OMM

855

$25.1K

270
240 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

64%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 8%

$29
Average prescription price

Avg: $74

KATAYOUN SABETIAN MD

Neuromusculoskeletal Medicine OMM

845

$320K

93
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 8%

$379
Average prescription price

Avg: $74

JACK YU MD

Neuromusculoskeletal Medicine OMM

734

$23.4K

95
84 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

46%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 8%

$32
Average prescription price

Avg: $74

RICHARD DELL MD

Neuromusculoskeletal Medicine OMM

696

$17.4K

195
171 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

33%
patients receiving schedule three controlled substances

Avg: 43%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

5%
prescriptions for brand name drugs

Avg: 8%

$25
Average prescription price

Avg: $74

KIRAN BATH M.D.

Neuromusculoskeletal Medicine OMM

686

$48.7K

125
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 43%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 8%

$71
Average prescription price

Avg: $74

CRAIG HARWIN MD

Neuromusculoskeletal Medicine OMM

645

$13.4K

207
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

58%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

3%
prescriptions for brand name drugs

Avg: 8%

$21
Average prescription price

Avg: $74

ROD BLAU MD

Neuromusculoskeletal Medicine OMM

618

$9,098

204
188 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

55%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

0%
prescriptions for brand name drugs

Avg: 8%

$15
Average prescription price

Avg: $74

MICHAEL RYAN MD

Neuromusculoskeletal Medicine OMM

531

$18.7K

185
161 are 65+

52%
patients receiving schedule two controlled substances

Avg: 8%

34%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

7%
prescriptions for brand name drugs

Avg: 8%

$35
Average prescription price

Avg: $74

ROBERT NAMBA MD

Neuromusculoskeletal Medicine OMM

516

$11.7K

230
212 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

44%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

7%
prescriptions for brand name drugs

Avg: 8%

$23
Average prescription price

Avg: $74

DAVID ANDERSON MD

Neuromusculoskeletal Medicine OMM

482

$8,502

205
184 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

32%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

7%
prescriptions for brand name drugs

Avg: 8%

$18
Average prescription price

Avg: $74

DAVID MESNA MD

Neuromusculoskeletal Medicine OMM

481

$12.1K

174
164 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

59%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

6%
prescriptions for brand name drugs

Avg: 8%

$25
Average prescription price

Avg: $74

JOHN PETERS MD

Neuromusculoskeletal Medicine OMM

429

$12.3K

201
186 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

29%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

7%
prescriptions for brand name drugs

Avg: 8%

$29
Average prescription price

Avg: $74

ARNOLD YASHAR MD

Neuromusculoskeletal Medicine OMM

389

$23.7K

160
145 are 65+

44%
patients receiving schedule two controlled substances

Avg: 8%

39%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 8%

$61
Average prescription price

Avg: $74

SOVANRITH TUN MD

Neuromusculoskeletal Medicine OMM

380

$5,447

170
154 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

54%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

3%
prescriptions for brand name drugs

Avg: 8%

$14
Average prescription price

Avg: $74

JOSEPH ABOUZEID MD

Neuromusculoskeletal Medicine OMM

337

$12.9K

191
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 8%

$38
Average prescription price

Avg: $74

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank